Related references
Note: Only part of the references are listed.Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline (vol 162, pg e207, 2022)
James D. Douketis et al.
CHEST (2023)
2021 ELSO Adult and Pediatric Anticoagulation Guidelines
Ali B. McMichael et al.
ASAIO JOURNAL (2022)
Regional anaesthesia in patients on antithrombotic drugs Joint ESAIC/ESRA guidelines
Sibylle Kietaibl et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2022)
Current practices of standardized risk assessment for venous thromboembolism: Results from a global survey from the World Thrombosis Day steering committee
Aaron M. Wendelboe et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban
Alexander P. Benz et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects
Jack Ansell et al.
EUROPEAN HEART JOURNAL (2022)
Addendum to the guideline on the peri-operative management of anti-coagulation and anti-platelet therapy (vol 175, pg 602, 2016)
Khalid Saja
BRITISH JOURNAL OF HAEMATOLOGY (2022)
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
Steven M. Greenberg et al.
STROKE (2022)
How to manage anticoagulation during extracorporeal membrane oxygenation
Jerrold H. Levy et al.
INTENSIVE CARE MEDICINE (2022)
Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage A Systematic Review and Meta-analysis
Rahul Chaudhary et al.
JAMA NETWORK OPEN (2022)
Perioperative Management of Antithrombotic Therapy An American College of Chest Physicians Clinical Practice Guideline
James D. Douketis et al.
CHEST (2022)
Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
Alex C. Spyropoulos et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2022)
A single center 9-year experience in IVC filter retrieval-the importance of an IVC filter registry
Mark Sheehan et al.
CVIR ENDOVASCULAR (2022)
Systematic review on the benefit of graduated compression stockings in the prevention of venous thromboembolism in low-risk surgical patients
M. Machin et al.
PHLEBOLOGY (2021)
Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants
Jack Ansell et al.
BLOOD (2021)
The Society for Obstetric Anesthesia and Perinatology Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia
Melissa E. Bauer et al.
ANESTHESIA AND ANALGESIA (2021)
Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis
Charlie J. Nederpelt et al.
CRITICAL CARE MEDICINE (2021)
A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation
Andrew J. Doyle et al.
CRITICAL CARE MEDICINE (2021)
Antithrombotic Therapy for VTE Disease Second Update of the CHEST Guideline and Expert Panel Report
Scott M. Stevens et al.
CHEST (2021)
Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
Antonio Gomez-Outes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Anticoagulation Management and Antithrombin Supplementation Practice during Veno-venous Extracorporeal Membrane Oxygenation A Worldwide Survey
Alessandro Protti et al.
ANESTHESIOLOGY (2020)
Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
Jennifer A. Frontera et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Another nail in the coffin of vena cava filters
A. J. Doyle et al.
BRITISH JOURNAL OF SURGERY (2020)
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants A Report of the American College of Cardiology Solution Set Oversight Committee
Gordon F. Tomaselli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Management and outcomes of newborns at risk for inherited antithrombin deficiency
Roza Chaireti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation
Mauro Panigada et al.
CRITICAL CARE MEDICINE (2020)
Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease
John A. Kaufman et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study
Alfonso J. Tafur et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Inferior vena cava filters: a framework for evidence-based use
Amar H. Kelkar et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Perioperative antithrombotic management of patients who receive direct oral anticoagulants during gastroenterological surgery
Takahisa Fujikawa et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers
Genmin Lu et al.
BLOOD ADVANCES (2020)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient-specific thromboembolic risk
Alex C. Spyropoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Preventing hospital associated venous thromboembolism
Beverley J. Hunt
BMJ-BRITISH MEDICAL JOURNAL (2019)
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
James D. Douketis et al.
JAMA INTERNAL MEDICINE (2019)
The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications
Mirjana Kovac et al.
THROMBOSIS RESEARCH (2019)
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum
Adam Cuker et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Robert C. Gosselin et al.
THROMBOSIS AND HAEMOSTASIS (2018)
International consensus statement on the peri-operative management of direct oral anticoagulants in cardiac surgery
G. Erdoes et al.
ANAESTHESIA (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy
Shannon M. Bates et al.
BLOOD ADVANCES (2018)
Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
Yvonne M. C. Henskens et al.
THROMBOSIS JOURNAL (2018)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Jose A. Lopez-Lopez et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis
Jose A. Lopez-Lopez et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
Bethany T. Samuelson et al.
CHEST (2017)
Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication
Adam Cuker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
Robert P. Giugliano et al.
AMERICAN JOURNAL OF MEDICINE (2016)
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
J. H. Levy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Effect of a Retrievable Inferior Vena Cava Filter Plus Anticoagulation vs Anticoagulation Alone on Risk of Recurrent Pulmonary Embolism A Randomized Clinical Trial
Patrick Mismetti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
Rick H. van Gorp et al.
NUTRIENTS (2015)
Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial
Claes Held et al.
EUROPEAN HEART JOURNAL (2015)
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
N. van Es et al.
BLOOD (2014)
Laboratory Measurement of the Anticoagulant Activity of the Non-Vitamin K Oral Anticoagulants
Adam Cuker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the US Adult Population
Susan Colilla et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient
Annika Bickford et al.
AMERICAN JOURNAL OF SURGERY (2013)
How I treat heterozygous hereditary antithrombin deficiency in pregnancy
Kate Bramham et al.
THROMBOSIS AND HAEMOSTASIS (2013)
The global burden of unsafe medical care: analytic modelling of observational studies
Ashish K. Jha et al.
BMJ QUALITY & SAFETY (2013)
Pros and cons of new oral anticoagulants
Kenneth A. Bauer
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
S. Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations
Andreas Tiede et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Guidelines on use of vena cava filters
T. P. Baglin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)